Evidence map›Paper›PMID 40702219›Full record

ArticleScientific reports2025

An explainable transformer model for Alzheimer's disease detection using retinal imaging.

Saeed Jamshidiha, Alireza Rezaee, Farshid Hajati, Mojtaba Golzan, Raymond Chiong

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saeed JamshidihaNanotechnology, Biotechnology, Information Technology and Cognitive Science Laboratory, University of Tehran, Tehran, Iran.
Alireza RezaeeDepartment of Mechatronics, School of Intelligent Systems, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran. arrezaee@ut.ac.ir.
Farshid HajatiSchool of Science and Technology, Faculty of Science, Agriculture, Business and Law, University of New England, Armidale, NSW, 2350, Australia.
Mojtaba GolzanGraduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Raymond ChiongSchool of Science and Technology, Faculty of Science, Agriculture, Business and Law, University of New England, Armidale, NSW, 2350, Australia.

Funding

University of New England, Australia A24/2676
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that affects millions worldwide. In the absence of effective treatment options, early diagnosis is crucial for initiating management strategies to delay disease onset and slow down its progression. In this study, we propose Retformer, a novel transformer-based architecture for detecting AD using retinal imaging modalities, leveraging the power of transformers and explainable artificial intelligence. The Retformer model is trained on datasets of different modalities of retinal images from patients with AD and age-matched healthy controls, enabling it to learn complex patterns and relationships between image features and disease diagnosis. To provide insights into the decision-making process of our model, we employ the Gradient-weighted Class Activation Mapping algorithm to visualise the feature importance maps, highlighting the regions of the retinal images that contribute most significantly to the classification outcome. These findings are compared to existing clinical studies on detecting AD using retinal biomarkers, allowing us to identify the most important features for AD detection in each imaging modality. The Retformer model outperforms a variety of benchmark algorithms across different performance metrics by margins of up to 11%.

Indexed as

Alzheimer DiseaseRetinaAgedAlgorithmsArtificial IntelligenceFemaleHumansImage Processing, Computer-AssistedMale

Identifiers

PMID40702219
PMCPMC12287274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.